TRIM21 and synovial sarcoma: Consistent with a recent report47, additional competition experiments revealed that TRIM38 was a minor autoantigen in SS with both autoantibodies specific for TRIM38, as well as autoantibodies cross-reacting with shared epitopes of Ro52.